awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34848038-9F71EB15-D1DE-45EB-AA8A-D2897DDC840A
Q34848038-9F71EB15-D1DE-45EB-AA8A-D2897DDC840A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34848038-9F71EB15-D1DE-45EB-AA8A-D2897DDC840A
Synergistic antitumor effect between gefitinib and fractionated irradiation in anaplastic oligodendrogliomas cannot be predicted by the Egfr signaling activity.
P2860
Q34848038-9F71EB15-D1DE-45EB-AA8A-D2897DDC840A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34848038-9F71EB15-D1DE-45EB-AA8A-D2897DDC840A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
77a3354ee49a58588a50f98ec14c6cdab24e564c
P2860
A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.